Clinical Trial Update: Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing two NN5401 formulations with metformin to insulin glargine, in adults with Type 2 diabetes; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NN5401 Formulation A (NN5401 formulation A)
• NN5401 Formulation B (NN5401 formulation B)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2015-11-17